About
Generics
Areas of Focus
Categories
Generic Drug
Clinical Trials (21)
View allTotal Trials
21
As Lead Sponsor
12
As Collaborator
9
Total Enrollment
8,129
By Phase
PHASE1: 4PHASE2: 1PHASE4: 1PHASE3: 2
By Status
COMPLETED: 19RECRUITING: 1TERMINATED: 1
Clinical Trials Pipeline21 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT06214130Lead Sponsor
Bioavailability of Orfiril Long 500 mg Prolonged-Release Minitablets and Ergenyl Chrono 500 mg Prolonged-Release Tablets
PHASE1Completed
22 participants
Started: Sep 22, 2023 · Completed: Nov 18, 2023
NCT06211283Lead Sponsor
Bioavailability and Food Effect of Sodium Valproate Minitablets in Healthy Subjects.
PHASE1Completed
28 participants
Started: Sep 11, 2023 · Completed: Nov 1, 2023
NCT06199791Lead Sponsor
Single-dose, Two-way Crossover Bioequivalence of Lamotrigine in Healthy Male Volunteers Under Fasting Conditions
PHASE1Completed
24 participants
Started: Apr 3, 2023 · Completed: Jun 14, 2023
NCT04927676Collaborator
Hormones in Hypogonadotropic Hypogonadism
N/ARecruiting
50 participants
Started: Apr 2, 2023 · Completed: Aug 31, 2024
NCT05236842Lead Sponsor
Efficacy, Safety and Tolerability of Sulthiame in Patients With Obstructive Sleep Apnea (OSA)
PHASE2Completed
298 participants
Started: Nov 23, 2021 · Completed: Aug 31, 2023
Locations (1)
Headquarters
Brehna, Germany
Map
Loading map...